Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis

Journal of Infection and Chemotherapy

Volumn 9, Issue 3, 2003, Pages 276-277

  Mikamo, Hiroshige ^a   Ninomiya, Mochiyoshi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ascites; Intravenous ciprofloxacin; Penetration; Pharmacokinetics

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; ASCITES; BIOASSAY; BLOOD; CASE REPORT; DRUG DETERMINATION; DRUG EFFICACY; DRUG PENETRATION; ESCHERICHIA COLI; HUMAN; PELVIS; PERITONITIS; SERUM;

EID: 0142090131     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0250-x     Document Type: Article

References (7)

1. Hussan MO, Izard D, Bouillet L, Leclerc H. Comparative in-vitro activity of ciprofloxacin against non-fermenters. J Antimicrob Chemother 1985;15:457-62.
2. Aikawa N, Sasaki J, Iwai S, Kunimatsu M, Furuhata H, Watanabe T, et al. Clinical investigation of intravenous ciprofloxacin in severe and/or refractory infections in surgical and gynecological fields (in Japanese). Jpn J Chemother 1997;45:936-50.
3. Ashihara Y, Yuki S, Kobayashi N, Asada Y. Studies on bioassay method of Bay o 9867 (ciprofloxacin) concentrations in body fluid (in Japanese). Chemotherapy 1985;33 S-7:76-80.
4. Thomson C. The global epidemiology of resistance to ciprofloxacin and changing nature of antibiotic resistance: a 10 year perspective. J Antimicrob Chemother 1999;43(Suppl A):31-40.
5. Jones RN, Kehrberg EN, Erwin ME. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistances: real or perceived? Diagn Microbiol Infect Dis 1994;19:203-15.
6. Davis R, Markham A, Balfour JA. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs 1996;51:1019-74.
7. Suzuki H, Aikawa N, Okusawa S, Takahashi T, Ishibiki K. Studies on clinical effect and excretion into peritoneal exudates of imipenem/cilastatin sodium in surgical patients. Chemotherapy 1985;33(S-4):942-9.